These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1642616)

  • 21. Approaches to coping with chronic fatigue syndrome (CFS).
    Stark FM; Sobetzko HM
    Zentralbl Hyg Umweltmed; 1999 Aug; 202(2-4):179-90. PubMed ID: 10507127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
    Buchwald D; Wener MH; Pearlman T; Kith P
    J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M; Welberg LA; Capuron L; Miller AH; Pagnoni G; Reeves WC
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?
    Staines DR
    Med Hypotheses; 2004; 62(5):646-52. PubMed ID: 15082083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.
    Weatherley-Jones E; Nicholl JP; Thomas KJ; Parry GJ; McKendrick MW; Green ST; Stanley PJ; Lynch SP
    J Psychosom Res; 2004 Feb; 56(2):189-97. PubMed ID: 15016577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic fatigue syndrome. 1: Etiology and pathogenesis.
    Farrar DJ; Locke SE; Kantrowitz FG
    Behav Med; 1995; 21(1):5-16. PubMed ID: 7579775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.
    Maes M; Mihaylova I; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Aug; 28(4):463-9. PubMed ID: 17693978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cognitive function and psychological characteristics of patients with chronic fatigue syndrome].
    Li YJ; Gao XG; Wang DX; Lin T; Bai XL; Yang FZ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2926-9. PubMed ID: 16324367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.
    Peakman M; Deale A; Field R; Mahalingam M; Wessely S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):83-91. PubMed ID: 9000046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic fatigue immune dysfunction syndrome].
    Uchida A
    Nihon Rinsho; 1992 Nov; 50(11):2625-9. PubMed ID: 1287238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immune function and the outcome of chronic fatigue syndrome.
    Wilson A; Hickie I; Lloyd A; Hadzi-Pavlovic D; Wakefield D
    Int J Immunopharmacol; 1995 Aug; 17(8):691-4. PubMed ID: 8847164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis.
    Natelson BH; LaManca JJ; Denny TN; Vladutiu A; Oleske J; Hill N; Bergen MT; Korn L; Hay J
    Am J Med; 1998 Sep; 105(3A):43S-49S. PubMed ID: 9790481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome.
    Peterson PK; Shepard J; Macres M; Schenck C; Crosson J; Rechtman D; Lurie N
    Am J Med; 1990 Nov; 89(5):554-60. PubMed ID: 2239975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stress, depression and schizophrenia in view of psychoimmunology].
    Dabkowska M; Rybakowski J
    Psychiatr Pol; 1992; 26(5):347-56. PubMed ID: 1302335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surface T-lymphocyte markers and monocyte dysfunction in the chronic fatigue syndrome].
    Castilla A; Subira ML; Civeira MP; Cuende JI
    An Med Interna; 1992 Apr; 9(4):207-8. PubMed ID: 1581462
    [No Abstract]   [Full Text] [Related]  

  • 37. Study of immune alterations in patients with chronic fatigue syndrome with different etiologies.
    Racciatti D; Dalessandro M; Delle Donne L; Falasca K; Zingariello P; Paganelli R; Pizzigallo E; Vecchiet J
    Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):57-62. PubMed ID: 15345193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between fatigue, psychological and immunological variables in acute infectious illness.
    Bennett BK; Hickie IB; Vollmer-Conna US; Quigley B; Brennan CM; Wakefield D; Douglas MP; Hansen GR; Tahmindjis AJ; Lloyd AR
    Aust N Z J Psychiatry; 1998 Apr; 32(2):180-6. PubMed ID: 9588296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome.
    Masuda A; Nozoe SI; Matsuyama T; Tanaka H
    Psychosom Med; 1994; 56(6):512-8. PubMed ID: 7871106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.
    Vollmer-Conna U; Hickie I; Hadzi-Pavlovic D; Tymms K; Wakefield D; Dwyer J; Lloyd A
    Am J Med; 1997 Jul; 103(1):38-43. PubMed ID: 9236484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.